Published Date : 2025-Apr-27
Glycomics and glycobiology are emerging as frontier sciences in understanding the role of glycans (complex sugars) in biological systems. Their applications span drug development, cancer diagnostics, vaccine design, and personalized medicine. Fueled by expanding biotechnology research and therapeutic advancements, the global glycomics/glycobiology market was valued at $1.2 billion in 2024, and is projected to reach $4.16 billion by 2032, growing at a strong CAGR of 14.8% (2024–2032), according to IMIR Market Research.
Let’s explore the top global companies includes in the blog includes.
Company | Headquarters | Founded | Employees | Revenue 2024 | |
Agilent Technologies, Inc. | California, USA | 1999 | 17,000+ | Approx. $7.5 Billion | |
Thermo Fisher Scientific Inc. | Massachusetts, USA | 1956 | 130,000+ | Approx. $43 Billion | |
Merck KGaA (MilliporeSigma in USA) | Darmstadt, Germany | 1668 | 64,500+ | Approx. $25 Billion | |
New England Biolabs | Massachusetts, USA | 1974 | Approx. 550 | Approx. $320 Million | |
Takara Bio Inc. | Shiga, Japan | 1967 | Approx. 1,600 | Approx. $400 Million | |
Waters Corporation | Massachusetts, USA | 1958 | 7,800+ | Approx. $2.9 Billion | |
Bruker Corporation | Massachusetts, USA | 1960 | 7,500+ | Approx. $2.8 Billion | |
Shimadzu Corporation | Kyoto, Japan | 1875 | 13,500+ | Approx. $4 Billion | |
Asparia Glycomics S.L. | San Sebastian, Spain | 2005 | Approx. 100 | Approx. $10 Million | |
RayBiotech, Inc. | Georgia, USA | 2001 | Approx. 150 | Approx. $30 Million |
Region | Growth Highlights | Drivers |
North America | Largest market share | Biotech R&D investment, cancer research, major pharma hubs (USA, Canada) |
Europe | Robust expansion | Government funding in genomics and bioinformatics (Germany, UK, France) |
Asia-Pacific | Fastest-growing | Rising healthcare infrastructure, aging population, booming pharma sectors (China, India, Japan) |
Middle East and Africa | Emerging market | Strategic partnerships, healthcare modernization (UAE, South Africa) |
South America | Steady growth | Government initiatives and expanding pharmaceutical industry (Brazil, Argentina) |
Glycomics and glycobiology are rapidly moving from a niche research area to a central pillar of biotechnology innovation. With breakthroughs in bioinformatics, advanced analytical tools, and an increasing demand for precision medicine, the glycomics/glycobiology industry is set for explosive growth through 2032.
Leading companies that invest early in R&D, strategic collaborations, and regional expansion will be best positioned to capitalize on the market boom.
Would you like me to add more details on specific companies or market trends? Let me know! CLICK HERE
Intellectual Market Insights Research is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including, Semiconductor, aerospace, Automation, Agriculture, Food & Beverages, Automotive, Chemicals and Materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports.
